Literature DB >> 17462956

Decreased blood dendritic cell counts in type 1 diabetic children.

Slavica Vuckovic1, Geoff Withers, Mark Harris, Dalia Khalil, Damien Gardiner, Inge Flesch, Sonia Tepes, Ristan Greer, David Cowley, Andrew Cotterill, Derek N J Hart.   

Abstract

In this study DC numbers, phenotype and DC responses to the Toll-like receptor (TLR)-3 ligand, poly I:C, were examined in new-onset Type 1 diabetes (T1D) patients (ND) and in established T1D patients (ED). Absolute blood myeloid DC (MDC) and plasmacytoid DC (PDC) numbers were decreased in ND and ED patients compared to age-matched controls. The decrease in MDC and PDC counts was less evident in patients with a combination of T1D and coeliac disease (CD) or CD alone. The age-dependent decline in blood DC numbers, found in control children, was not evident in ND patients, such that 2-10 years old ND children had similar MDC and PDC numbers to 15-17 years old controls. In ED patients the t-score of MDC and PDC numbers related to the age of diagnosis but not to disease duration. Blood DC in T1D patients were not distinguished from those of controls by the levels of HLA-DR, CD40 and CD86 expression or the percentage of DC expressing cytokines, IL-12, IL-10, IL-6 and TNF-alpha, in responses to poly I:C. If low DC numbers are shown to contribute to the autoimmunity in T1D, interventions aimed to increase DC numbers may mitigate against beta-cell loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462956     DOI: 10.1016/j.clim.2007.03.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  25 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients.

Authors:  A Oras; A Peet; T Giese; V Tillmann; R Uibo
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

Review 3.  Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.

Authors:  S M Cabrera; M R Rigby; R G Mirmira
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

Review 4.  It's reticulated: the liver at the heart of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Sunil K Noothi; Michelle C Flynn; Andrew J Murphy
Journal:  J Endocrinol       Date:  2018-05-02       Impact factor: 4.286

5.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

6.  The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus.

Authors:  Hsuen-Wen Chang; Yen-Hung Chow; Pele Chong; Charles Sia
Journal:  Rev Diabet Stud       Date:  2007-08-10

7.  Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.

Authors:  Xueqin Chen; Levi H C Makala; Yulan Jin; Diane Hopkins; Andy Muir; Nikhil Garge; Robert H Podolsky; Jin-Xiong She
Journal:  Clin Immunol       Date:  2008-09-30       Impact factor: 3.969

8.  Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension.

Authors:  Weiyan Wang; Hui Yan; Weiguo Zhu; Yu Cui; Junzhu Chen; Xingxiang Wang; Shan Li; Jianhua Zhu
Journal:  J Clin Immunol       Date:  2009-08-20       Impact factor: 8.317

Review 9.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

10.  Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette.

Authors:  John P Driver; Felix Scheuplein; Yi-Guang Chen; Alexandra E Grier; S Brian Wilson; David V Serreze
Journal:  Diabetes       Date:  2009-11-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.